Liu · Frontiers in immunology 2021 · narrative review · n=?

Circulating Mitochondrial DNA Stimulates Innate Immune Signaling Pathways to Mediate Acute Kidney Injury.

Cited 62 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review synthesizing mechanistic pathways without systematic review methods or original data

PubMed 34248963 · doi:10.3389/fimmu.2021.680648 · record verified 2026-08-31

What was done

The authors summarized literature on how damaged mitochondria and circulating mitochondrial DNA (mtDNA) drive acute kidney injury (AKI). The review explores the role of mtDNA as a danger-associated molecular pattern (DAMP) activating innate immune cascades.

What was found

The abstract reports no numerical findings or quantitative effect sizes. It qualitatively describes that released mtDNA activates the innate immune system via STING, TLR9, NLRP3, and other adaptors, leading to renal tubular cell inflammation and apoptosis.

Why it matters

Modulating circulating mtDNA and its downstream innate immune signaling pathways may offer potential therapeutic targets to reduce tubular injury in AKI.

Limits

This is a narrative review presenting mechanistic theory rather than an empirical trial or systematic review. The abstract provides no sample sizes, effect estimates, search methodology, or clinical validation.

Cited by